![]() ![]() ![]() Single-cell RNA-seq with 10x Genomics 5' paired-end Libraries were constructed using Chromium™ Single Cell 5' v1 Reagent Kits following the manufacturer’s protocolġ00 x 100 bp paired-end reads, 3'TAG, Hg19 human reference genome. Single-cell RNA-seq using 10x genomics platform was performed using Chromium™ Single Cell 5' v1 Reagent Kits following the manufacturer’s protocol Following careful mixing, 33 µl of the cell suspension was transferred to a PCR-tube for processing as per the manufacturer’s instructions (10x Genomics). 25 µl of resuspension buffer (0.22 µm filtered ice-cold PBS supplemented with ultra-pure bovine serum albumin 0.04 %, Sigma-Aldrich) was added to the tube and the pellet was gently but thoroughly resuspended. Cells were then centrifuged for 5 minutes (600 g at 4 ˚C) and the supernatant was carefully removed leaving 5 to 10 µl. Following sorting, ice-cold PBS was added to make up to a volume of 1400 µl. Following elution, enriched populations were immediately sorted using a FACSAria Fusion Cell Sorter (Becton Dickinson) based on dual expression of CD154 and CD69 for 6-hour stimulation condition, and CD137 and CD69 for 24-hour stimulation condition.įor combined single-cell RNA-seq and TCR-seq assays (10x Genomics), a maximum of 60,000 virus-reactive memory CD4+ T cells from up to 8 donors were pooled by sorting into low retention 1.5mL collection tubes, containing 500 µL of a1:1 solution of PBS:FBS supplemented with RNAse inhibitor (1:100). The flow-through from the column was collected and re-plated for harvesting cells responding 24 h after peptide stimulation.Īnalogous to enrichment for CD154+, CD137-expressing CD4+ memory T cells cells were positively selected by staining with biotin-conjugated CD137 antibody (clone REA765 Miltenyi Biotec) followed by anti-biotin MicroBeads and applied to a new MS column. Labelled cells were added to MS columns (Miltenyi Biotec) and positively selected cells (CD154+) were eluted and used for FACS sorting of CD154+ memory CD4+ T cells. For subsequent MACS-based enrichment of CD154+, cells were sequentially stained with fluorescence-labeled surface antibodies, Cell-hashtag TotalSeq™-C antibody (0.5 µg/condition), and a biotin-conjugated CD154 antibody (clone 5C8 Miltenyi Biotec) followed by anti-biotin microbeads (Miltenyi Biotec). Cells were stimulated by the addition of individual virus-specific peptide polls (1 µg/ml) for 6 h in the presence of a blocking CD40 antibody (1 µg/ml Miltenyi Biotec). PBMCs from each donor, were thawed, washed, plated in 6-well culture plates at a concentration of 5 x 106 cells/ml in 1 ml of serum-free TexMACS medium (Miltenyi Biotec) and left overnight (5 % CO2, 37 ˚C). In the US, MACS GMP T Cell TransAct is for use under an approved IND.GEO help: Mouse over screen elements for information.Ĭell type: Memory CD4 T cells, helper enriched: CD3+ CD4+ CD45RA- CD154+ CD69+ MACS GMP T Cell TransAct is suitable for the use in automated cell manufacturing systems, such as the CliniMACS Prodigy. The reagent is finely tuned to work best in combination with TexMACS™ GMP Medium. Excess reagent can be removed by simple supernatant replacement. Safety: Biodegradable, ready to use and compatible with the automated, functionally-closed CliniMACS Prodigy® System.ĭue to the nanoscale structure of MACS GMP T Cell TransAct, the reagent can be sterile filtered.Convenience: Excess reagent is simply washed off.Ease of use: Effective activation for a large range of cell densities.Innovative format: A colloidal polymeric nanomatrix conjugated to humanized, recombinant CD3 and CD28 agonists.Polyclonal T cell expansion can be used in numerous applications including cellular therapy or whenever T cells are activated to improve gene modification.īenefits of MACS GMP T Cell TransAct are: ![]() MACS GMP T Cell TransAct from Miltenyi Biotec – with its unique features – enables in vitro stimulation, activation, and expansion of human T cells from hematological cell populations (e.g. Also available in research grade.Ĭell activation is a prerequisite for the successful genetic engineering of T cells. MACS ® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. LC-MS innovation: Improve analytical accuracy Which microbioreactor modules are best for you ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |